WALNUT CREEK, Calif., April 27, 2017 /PRNewswire/ -- Providence Medical Technology, Inc., an innovator in tissue-sparing
These patents cover, among other things, posterior placement of an implant in a facet joint using a chisel and guide tube; placement of an implant in a facet joint using a forked guide tube; placement of implants of various configurations in a cervical facet joint; and distraction of a facet joint after posterior placement of an implant in the facet joint.
These four recent issuances bring the number of issued patents in Providence's growing patent portfolio to 35 total. Providence has already filed approximately 40 other applications in various stages of prosecution in the U.S. and overseas covering various aspects of its proprietary technologies.
"We have invested tremendous resources over the years in filing both broad and detailed disclosures covering the important aspects of our technology for tissue-sparing posterior cervical and spinal intervention," commented Jeff Smith, Chief Executive Officer. "We are extremely pleased with the continued and accelerating growth of our patent portfolio as it provides the means to protect our innovations and rapidly expanding business."
About Providence Medical Technology, Inc.Providence Medical Technology, Inc. is a privately-held medical device company focused on innovative solutions for cervical spinal conditions. The company has pioneered a proprietary, tissue-sparing approach to posterior cervical fusion. Providence has developed surgical instrumentation and implants that offer unique benefits in the $2 billion worldwide cervical spine market. The Providence family of products includes the DTRAX® Spinal Instrumentation System, CAVUX® intervertebral implants, and the ALLY™ line of bone and facet screws. All products are shipped-sterile and single-use to maximize efficiency and ensure consistent quality and performance. For more information, visit www.providencemt.com.
Related Links: www.providencemt.com; www.providencemt.com/intellectualproperty/
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/providence-medical-technology-announces-issuance-of-four-additional-us-patents-300446937.html
SOURCE Providence Medical Technology, Inc.
Subscribe to our Free Newsletters!
Neuroblastoma is a very rare type of childhood cancer that develops in immature nerve cells ...
Video-electroencephalography monitoring is a diagnostic technique that records the electrical ...
Myomectomy is a surgery that is done to remove fibroids, which are non-cancerous growths of the ...View All